Takeda and Moderna Announce Plans to Transfer Marketing Authorization for SpikevaxTM ...

Retrieved on: 2022-05-31 14:17:15

Tags for this article:

COVID-19 vaccination in the United States

Clinical trials

Moderna COVID-19 vaccine

COVID-19 vaccine

Vaccine

COVID-19 vaccination in Canada

Deployment of COVID-19 vaccines

Moderna, Inc.

Japan

Takeda Pharmaceutical Company Limited

Click the tags to see associated articles and topics

Takeda and Moderna Announce Plans to Transfer Marketing Authorization for SpikevaxTM .... View article details on HISWAI: https://www.marketscreener.com/quote/stock/MODERNA-INC-47437573/news/Takeda-and-Moderna-Announce-Plans-to-Transfer-Marketing-Authorization-for-SpikevaxTM-COVID-19-Vaccin-40598015/

Excerpt

CAMBRIDGE - Moderna, Inc. , (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Takeda (TSE: ...

Article found on: www.marketscreener.com

View Original Article